2026-06-08T04:03:24Zhttps://docta.ucm.es/rest/oai/requestoai:docta.ucm.es:20.500.14352/935862024-04-04T17:57:43Zcom_20.500.14352_14col_20.500.14352_15
https://hdl.handle.net/20.500.14352/93586/ore.xml
2024-01-17T11:53:57Z
2024-01-17T11:53:57Z
Docta Complutense
Ruxolitinib in combination with prednisone and nilotinib exhibit synergistic effects in human cells lines and primary cells from myeloproliferative neoplasms
Arenas Cortés, Alicia
Ayala Díaz, Rosa María
Hernández-Campo, Pilar
Gorrochategui, Julián
Primo Niembro, Daniel Arturo
Robles, Alicia
Morales, María Luz
Ballesteros, Joan
Rapado, Inmaculada
Gallardo, Miguel
Linares Gómez, María
Martínez López, Joaquín
2024-01-17T11:53:57Z
LICENSE
ORIGINAL
TEXT
THUMBNAIL